Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
Picard Medical, Inc.
Delisting risk
confidence 98%
filed 2026-05-21
Item 3.01
The filing discloses a written notice from NYSE American on May 15, 2026, indicating non-compliance with continued listing standards due to stockholders' deficit of approximately $1.4 million against a required minimum of $2.0 million, combined with losses in three consecutive fiscal years. The Company must submit a compliance plan by June 7, 2026, or face delisting procedures by November 8, 2027. This is a classic delisting risk disclosure under Item 3.01.
View raw filing on EDGAR →
Picard Medical, Inc.
Delisting risk
confidence 95%
filed 2026-05-21
Item 7.01
The filing discloses receipt of "Notices" regarding "continued listing standards that the Company has fallen below," which is the hallmark language of a delisting notice from a stock exchange. This is a material event that would directly affect investor assessment of the registrant's ability to maintain its public listing status.
View raw filing on EDGAR →
Algorhythm Holdings, Inc.
Delisting risk
confidence 95%
filed 2026-05-21
The filing discloses that Algorhythm Holdings received a Nasdaq delisting notice on November 28, 2025 for failing to maintain the required $2.5 million stockholders' equity under Listing Rule 5550(b)(1), and while the company claims to have regained compliance as of March 31, 2026, Nasdaq explicitly warned that "if at the time of its next periodic report the Company does not evidence compliance, the Company may be subject to delisting." This is a material delisting risk disclosure under Item 8.01.
View raw filing on EDGAR →
Aterian, Inc.
Delisting risk
confidence 85%
filed 2026-05-21
Item 8.01
The filing discloses a delisting risk event: Aterian received a Nasdaq notice on December 9, 2025 that it failed to maintain the minimum $1.00 bid price requirement under Nasdaq Listing Rule 5550(a)(2), triggering a 180-day cure period. Although the company subsequently regained compliance by May 19, 2026, the core event disclosed is the delisting notice and the company's status relative to continued listing standards. This is material to investors as it directly affects the registrant's exchange listing status.
View raw filing on EDGAR →
VenHub Global, Inc.
Delisting risk
confidence 92%
filed 2026-05-21
Item 8.01
The filing discloses that VenHub Global has regained compliance with Nasdaq Listing Rule 5450(a)(1) after the closing bid price of its Common Stock remained at $1.00 or greater for 10 consecutive business days. This directly addresses a delisting risk — the company was previously non-compliant with the minimum bid price rule and has now cured that deficiency. The materiality is high because delisting risk materially affects investor assessment of the registrant's continued market access and trading liquidity.
View raw filing on EDGAR →
Quince Therapeutics, Inc.
Delisting risk
confidence 95%
filed 2026-05-21
Item 8.01
The Company disclosed receipt of a Nasdaq notice on March 17, 2026 that it had failed to maintain the minimum market value of listed securities ($50 million) required under Nasdaq Listing Rule 5450(b)(2)(A). Although the Company subsequently regained compliance by May 20, 2026 based on stockholders' equity meeting Rule 5450(b)(1)(A), the disclosure centers on a delisting risk event—the failure to satisfy a continued listing rule and the subsequent resolution. This is material to investors as it directly affects the Company's ability to remain listed on Nasdaq.
View raw filing on EDGAR →
Innventure, Inc.
Delisting risk
confidence 92%
filed 2026-05-20
Item 3.01
The filing discloses a failure to satisfy Nasdaq Listing Rule 5605(c)(2)(A) following Daniel Hennessy's resignation from the Audit Committee, which reduced the committee below the required three independent members. Although the Company subsequently regained compliance on May 15, 2026 through Bruce Brown's appointment and Nasdaq confirmed restoration of compliance on May 19, 2026, the Item 3.01 disclosure itself documents the delisting risk event and its resolution. This is material to investors as it reflects governance compliance issues and potential listing jeopardy.
View raw filing on EDGAR →
TOMI Environmental Solutions, Inc.
Delisting risk
confidence 98%
filed 2026-05-20
Item 3.01
The Company received formal notice from Nasdaq on May 19, 2026, that its Common Stock will be delisted from The Nasdaq Capital Market due to failure to regain compliance with the minimum bid price requirement ($1.00 per share) and stockholders' equity requirement ($2.5 million). This is a definitive delisting notice, not merely a warning or compliance period, making it a material event that directly affects the registrant's listing status and investor access to the security.
View raw filing on EDGAR →
Aimei Health Technology Co., Ltd.
Delisting risk
confidence 98%
filed 2026-05-20
The filing discloses that on May 19, 2026, Aimei Health Technology received a notice from Nasdaq's Listing Qualifications Department stating the Company is not in compliance with Nasdaq Listing Rule 5250(c)(1) due to failure to timely file its Form 10-Q for the quarter ended March 31, 2026. The notice explicitly states that if the Company fails to regain compliance, "the Company's securities will be subject to delisting from Nasdaq." This is a classic delisting risk disclosure under Item 3.01.
View raw filing on EDGAR →
SOCIETY PASS INCORPORATED.
Delisting risk
confidence 95%
filed 2026-05-20
Item 3.01
The filing discloses that Nasdaq notified the Company on May 14, 2026 of its determination to delist the Company's common stock pursuant to Nasdaq Listing Rules 5101, 5110(b), and IM-5101-1 as a result of the Company's Chapter 11 bankruptcy filing. Trading will be suspended on May 21, 2026, and a Form 25-NSE will be filed to remove the Common Stock from listing and registration on Nasdaq. This is a material delisting event that directly affects the registrant's public market access.
View raw filing on EDGAR →
Evolution Metals & Technologies Corp.
Delisting risk
confidence 85%
filed 2026-05-20
Item 8.01
The Company discloses that it will not file its Q1 2026 Form 10-Q within the Rule 12b-25 extension period and anticipates receiving a notice of non-compliance from Nasdaq under Listing Rule 5250(c)(1) due to the late filing. While the Company expects the notice to have no immediate effect on listing and anticipates a grace period to regain compliance, the disclosure of anticipated non-compliance with continued listing rules and the potential for delisting consequences constitutes a delisting_risk event. The materiality is clear given the direct impact on the Company's ability to maintain its Nasdaq listing.
View raw filing on EDGAR →
Singularity Future Technology Ltd.
Delisting risk
confidence 98%
filed 2026-05-20
Item 3.01
The filing discloses that Singularity Future Technology Ltd. received a Nasdaq staff determination notice on November 19, 2025, for failure to maintain the $1 minimum bid price required under Nasdaq Listing Rule 5550(a)(2). The Company was initially granted a 180-day compliance period (until May 18, 2026) and subsequently granted a second 180-day compliance period (until November 16, 2026). The disclosure explicitly states that if the Company does not regain compliance by the Compliance Date, Nasdaq will provide written notification that the Company's securities are subject to delisting. This is a classic delisting risk disclosure under Item 3.01.
View raw filing on EDGAR →
Twenty One Capital, Inc.
Delisting risk
confidence 92%
filed 2026-05-20
Item 3.01
The filing discloses a notice of non-compliance with NYSE continued listing rules. Specifically, the resignation of Jared Roscoe from the board resulted in the audit committee falling below the minimum two independent directors required under NYSE Listed Company Manual Section 303A.07(a). The Company notified NYSE of this non-compliance on May 20, 2026, creating delisting risk until the deficiency is remedied.
View raw filing on EDGAR →
SOCKET MOBILE, INC.
Delisting risk
confidence 98%
filed 2026-05-20
Socket Mobile received a Nasdaq deficiency notice on May 19, 2026 (Item 3.01) stating the company failed to maintain the minimum bid price of $1.00 per share for 30 consecutive business days, triggering a 180-day cure period ending November 16, 2026. The filing explicitly warns that failure to regain compliance could result in delisting, which would materially impair the company's ability to trade, raise capital, and maintain market value. This is a classic delisting-risk disclosure.
View raw filing on EDGAR →
Bitcoin Depot Inc.
Delisting risk
confidence 95%
filed 2026-05-19
Item 3.01
The filing discloses that Nasdaq has notified Bitcoin Depot that trading of its Class A common stock and warrants will be suspended effective May 26, 2026, and a Form 25-NSE will be filed to remove the securities from listing and registration on Nasdaq. This is a direct delisting notice triggered by the company's Chapter 11 bankruptcy filing and failure to timely file its Form 10-Q, making this a clear delisting_risk event under Item 3.01.
View raw filing on EDGAR →
Mister Car Wash, Inc.
Delisting risk
confidence 95%
filed 2026-05-19
Item 3.01
The filing explicitly discloses that on May 19, 2026, Mister Car Wash notified NASDAQ of a certificate of merger and requested delisting of its common stock (ticker "MCW") from NASDAQ via Form 25 filing with the SEC. Trading was suspended prior to market open on May 19, 2026, and the company intends to file Form 15 to deregister and terminate reporting obligations. This is a material delisting event triggered by a merger consummation.
View raw filing on EDGAR →